Public Company News
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic,...
2025-06-04 08:00
6205
Straker Limited (ASX: STG) - Straker launches integration with n8n
AUCKLAND, New Zealand, June 3, 2025 /PRNewswire/ -- Straker Limited (ASX: STG) ("Straker" or the "Company"), a global leader in AI-powered language technology solutions, is pleased to announce a strategic integration with n8n, a widely adopted AI automation platform with over 230,000 active users...
2025-06-04 06:55
1676
OREiN Launches World's First Matter-Certified Smart Bathroom Exhaust Fan, Advancing AiDot's Leadership in Smart Home Innovation
LOS ANGELES, June 3, 2025 /PRNewswire/ -- With the official release of the
Matter 1.3 protocol, AiDot
2025-06-03 21:00
2138
Energys Group Secures New Energy Efficient Lighting Contracts Upon Successful Completion of Initial Phase
BILLINGSHURST, UK, June 3, 2025 /PRNewswire/ -- Energys Group Limited (NASDAQ: ENGS) ("Energys Group" or the "Company", together with its subsidiaries, the " Group"), a vertically integrated energy efficiency and decarbonisation solutions provider for the built environment, is pleased to announce ...
2025-06-03 19:36
1837
e-STORAGE's SolBank 3.0 Successfully Passes Large-Scale Fire Testing (LSFT)
KITCHENER, ON, June 3, 2025 /PRNewswire/ -- Canadian Solar Inc
2025-06-03 19:00
1772
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2025-06-03 09:00
3628
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
2025-06-03 09:00
5450
Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025
BEIJING, June 2, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes of JensC...
2025-06-03 09:00
1633
FiEE, Inc. Closes Its First Day of Trading on NASDAQ
Company resumed trading under its existing symbol "MINM" HONG KONG, June 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE, Inc." or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, commenced the trading o...
2025-06-03 06:00
3528
Health In Tech Chief Growth Officer to Be Featured on "New to The Street" Interview at NYSE
STUART, Fla., June 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to share that Chief Growth OfficerDustin Plantholt will be featured in an upcoming interview on "New to The Street," filmed live at the New York S...
2025-06-02 20:45
3152
Taoping Selected for New US$2.8 Million Agricultural Product Supply Contract; Company Continues to Build Momentum in Important Growth Market
SHENZHEN, China, June 2, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that it has been selected for a newRMB 20 million ( US$2.8 million) sales and purchase agreement. Under the latest agreeme...
2025-06-02 20:30
3064
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene au...
2025-06-02 08:15
1794
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2025-06-02 08:00
3656
China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading
BEIJING, June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), aChina-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that onMay 30, 2025, th...
2025-06-01 20:00
3843
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, opht...
2025-06-01 09:39
5265
Zeekr Group Announces May 2025 Delivery Update
HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forMay 2025. In May, Zeekr Group delivered a total of 46,538 vehicles...
2025-06-01 09:30
2975
9F Inc. Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F
BEIJING, May 30, 2025 /PRNewswire/ -- 9F Inc. ("9F" or the "Company") (Nasdaq: JFU), a digital technology service provider aiming to empower institutional partners with advanced financial technologies, today announced that it received a notification letter datedMay 23, 2025 (the "Notification Let...
2025-05-31 04:30
4804
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)
SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtaine...
2025-05-30 22:00
2326
mF International Limited Announces Results of Annual General Meeting
HONG KONG, May 30, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), aHong Kong-based experienced financial trading solution provider, today announced the results of its annual general meeting of shareholders held inHong Kong on May 30, 2025. At t...
2025-05-30 19:00
3579
Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results
XIAMEN, China, May 30, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedMarch 31, 2025. First Quarter 2025 Financial Highlights: * Total revenue...
2025-05-30 18:00
3939
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 275 media titles]
2025-12-26 12:55Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026
[Picked up by 263 media titles]
2025-12-22 15:56
"Nihao China" App Launches as an All-in-One Solution for International Visitors
[Picked up by 253 media titles]
2025-12-24 17:54Sobot Shines in G2 Winter 2026: A New Benchmark in AI Customer Service
[Picked up by 252 media titles]
2025-12-24 10:00